COVID-19 in Patients With Chronic Liver Diseases

Purpose

This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.

Conditions

  • COVID-19
  • Chronic Liver Disease

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Confirmed diagnosis of COVID-19 - Personal history of either - Chronic hepatitis C - Chronic hepatitis B - Alcoholic liver disease - Non alcoholic liver disease - Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis - Cryptogenic cirrhosis - Hepatocellular carcinoma

Exclusion Criteria

  • Non-COVID-19 patient

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Chronic Liver Disease Group COVID-19 patients with Chronic Liver Disease.
  • Other: Prospective Chart Review
    Collected data will include demographic features, clinical characteristics, clinical outcome, medication use, COVID-19-related complications in patients with chronic liver disease.
Control Group COVID-19 patients without Chronic Liver Disease.
  • Other: Prospective Chart Review
    Collected data will include demographic features, clinical characteristics, clinical outcome, medication use, COVID-19-related complications in patients with chronic liver disease.

Recruiting Locations

More Details

NCT ID
NCT04439084
Status
Completed
Sponsor
Stanford University